Tradestie Institutional Equity Comparison Engine
PASG vs PYPD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PYPD Overall Edge
PYPD Captures Institutional Edge (2โ1 Pillars ยท 4โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PolyPid Ltd. Ordinary Shares (PYPD) driven by superior Momentum & Technical, Options & Structure while PASG counters with relative strength in Growth & Margin. Fundamentally, PASG trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PYPD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PASG sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against PYPD sits in BREAKOUT (12th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PASG N/M vs PYPD N/M Fwd P/E
Growth & Margin Winner
PASG
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
PYPD
1Y -52.4% vs +81.0% ยท 52W Pos 6% vs 82%
Options & Structure Winner
PYPD
UNCLASSIFIED (50th %ile IV) vs BREAKOUT (12th %ile IV)
PASG
NASDAQ
Passage Bio, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.21
+1.94% 1D
Market Cap
$13.7M
1M Return
+17.6%
1Y Return
-52.43%
Forward P/E
N/M
Unified AI Score
21.6 / 100
STRONG SELL
Tech 3.0
Fund 31.0
Flow 50.0
Mom 40.0
PYPD
NASDAQ
PolyPid Ltd. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$6.50
+5.63% 1D
Market Cap
$132.2M
1M Return
+33.12%
1Y Return
+80.95%
Forward P/E
N/M
Unified AI Score
31.1 / 100
SELL
Tech 50.0
Fund 27.0
Flow 56.0
Mom 32.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PASG -52.43%
PYPD +80.95%
Spread: +133.38 pp (PYPD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PASG TTM Op. Margin: 0.0%
PYPD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PASG vs PYPD. Trailing 12-month operating profitability (PASG 0.0% vs PYPD 0.0%) and valuation multiples (PASG N/M vs PYPD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PASG | PYPD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.7M | $132.2M | Larger Scale | PYPD |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -212.3% | -243.6% | Higher ROE | PASG |
| 52-Week Range Position Momentum | 6% ($3โ$20) | 82% ($4โ$7) | Stronger Trend | PYPD |
| Beta / 30D Volatility Risk Regime | 1.64ฮฒ ยท 90% Vol | 0.88ฮฒ ยท 59% Vol | Lower Realized Risk | PYPD |
| Unified Institutional Score Composite Signal | 21.6 / 100 (STRONG SELL) | 31.1 / 100 (SELL) | Higher Composite | PYPD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PASG vs PYPD Buy Guide
PASG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
PYPD
BREAKOUT
40d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
12th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PASG nor PYPD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.